N/A
N=56
Vitamin D Supplementation in Healthy Adolescents
Vitamin D Supplementation
Bottom Line
View on ClinicalTrials.gov: NCT01126671 ↗Enrolled (actual)
56
Serious AEs
0.0%
Results posted
Apr 2013
Primary outcome: Primary: Baseline 25 Hydroxy Vitamin D (25OHD) Levels — 28.1; 29 ng/ml
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Supplemental Vitamin D (Drug)
- Age
- Pediatric, Adult · 11+ yrs
- Sex
- All
- Sponsor
- Boston Children's Hospital
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Baseline 25 Hydroxy Vitamin D (25OHD) Levels |
28.1; 29 | — |
| PRIMARY Follow-up 25OHD Levels |
28.9; 30.1 | — |
| SECONDARY Baseline Assessment of Bone Markers |
1.4; 1.74 | — |
| SECONDARY Assessment of Bone Markers at Follow-up |
31.1; 32.3 | — |
Summary
This double blind, randomized controlled trial compares two supplemental doses of vitamin D in health adolescents.
Eligibility Criteria
Inclusion Criteria
- 11-18 years old
- healthy
Exclusion Criteria
- chronic disease
- use of medication known to effect bone or vitamin D metabolism
- abnormal vitamin D or calcium at screening
- pregnant
- body mass index 95%
Data sourced from ClinicalTrials.gov (NCT01126671). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.